199 related articles for article (PubMed ID: 11293945)
1. Different patterns of angioedema in patients with and without angiotensin-converting enzyme inhibitor therapy.
Herkner H; Temmel AF; Müllner M; Havel C; Hirschl MM; Kofler J; Laggner AN
Wien Klin Wochenschr; 2001 Mar; 113(5-6):167-71. PubMed ID: 11293945
[TBL] [Abstract][Full Text] [Related]
2. Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department.
Banerji A; Clark S; Blanda M; LoVecchio F; Snyder B; Camargo CA
Ann Allergy Asthma Immunol; 2008 Apr; 100(4):327-32. PubMed ID: 18450117
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin converting enzyme inhibitor-induced angioedema more prevalent in transplant patients.
Abbosh J; Anderson JA; Levine AB; Kupin WL
Ann Allergy Asthma Immunol; 1999 May; 82(5):473-6. PubMed ID: 10353579
[TBL] [Abstract][Full Text] [Related]
4. Increased C-reactive protein in ACE-inhibitor-induced angioedema.
Bas M; Hoffmann TK; Bier H; Kojda G
Br J Clin Pharmacol; 2005 Feb; 59(2):233-8. PubMed ID: 15676047
[TBL] [Abstract][Full Text] [Related]
5. The role of ace gene polymorphism in the development of angioedema secondary to angiotensin converting enzyme inhibitors and angiotensin II receptor blockers.
Gulec M; Caliskaner Z; Tunca Y; Ozturk S; Bozoglu E; Gul D; Erel F; Kartal O; Karaayvaz M
Allergol Immunopathol (Madr); 2008; 36(3):134-40. PubMed ID: 18680700
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme inhibitor-induced angioedema in a community hospital emergency department.
Bluestein HM; Hoover TA; Banerji AS; Camargo CA; Reshef A; Herscu P
Ann Allergy Asthma Immunol; 2009 Dec; 103(6):502-7. PubMed ID: 20084844
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.
Heinze G; Mitterbauer C; Regele H; Kramar R; Winkelmayer WC; Curhan GC; Oberbauer R
J Am Soc Nephrol; 2006 Mar; 17(3):889-99. PubMed ID: 16481415
[TBL] [Abstract][Full Text] [Related]
8. Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment.
Cicardi M; Zingale LC; Bergamaschini L; Agostoni A
Arch Intern Med; 2004 Apr; 164(8):910-3. PubMed ID: 15111379
[TBL] [Abstract][Full Text] [Related]
9. Brief review: angiotensin converting enzyme inhibitors and angioedema: anesthetic implications.
Sarkar P; Nicholson G; Hall G
Can J Anaesth; 2006 Oct; 53(10):994-1003. PubMed ID: 16987854
[TBL] [Abstract][Full Text] [Related]
10. Incidence and characteristics of angioedema associated with enalapril.
Kostis JB; Kim HJ; Rusnak J; Casale T; Kaplan A; Corren J; Levy E
Arch Intern Med; 2005 Jul; 165(14):1637-42. PubMed ID: 16043683
[TBL] [Abstract][Full Text] [Related]
11. Late onset angiotensin-converting enzyme induced angioedema: case report and review of the literature.
Guo X; Dick L
J Okla State Med Assoc; 1999 Feb; 92(2):71-3. PubMed ID: 10024785
[TBL] [Abstract][Full Text] [Related]
12. Analysis of recurrent angiotensin converting enzyme inhibitor-induced angioedema.
Roberts DS; Mahoney EJ; Hutchinson CT; Aliphas A; Grundfast KM
Laryngoscope; 2008 Dec; 118(12):2115-20. PubMed ID: 19029862
[TBL] [Abstract][Full Text] [Related]
13. Risk factors associated with severe and recurrent angioedema: an epidemic linked to ACE-inhibitors.
Loftus PA; Tan M; Patel G; Lin J; Helman S; Badhey A; Du E; Smith RV; Fried MP; Ow TJ
Laryngoscope; 2014 Nov; 124(11):2502-7. PubMed ID: 24938823
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series.
Bas M; Greve J; Stelter K; Bier H; Stark T; Hoffmann TK; Kojda G
Ann Emerg Med; 2010 Sep; 56(3):278-82. PubMed ID: 20447725
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin converting enzyme inhibitors and the allergist.
O'Hollaren MT; Porter GA
Ann Allergy; 1990 Jun; 64(6):503-6. PubMed ID: 2189318
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme inhibitor (ACE-I)- and angiotensin receptor blocker (ARB)-related angioedema: a neglected issue in daily practice in Greece.
Symvoulakis EK; Kyrmizakis DE; Drivas EI; Bizakis J; Velegrakis GA; Lionis C
Eur J Gen Pract; 2007; 13(4):239-41. PubMed ID: 18324507
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme inhibitor-associated angioedema is characterized by a slower degradation of des-arginine(9)-bradykinin.
Molinaro G; Cugno M; Perez M; Lepage Y; Gervais N; Agostoni A; Adam A
J Pharmacol Exp Ther; 2002 Oct; 303(1):232-7. PubMed ID: 12235256
[TBL] [Abstract][Full Text] [Related]
18. Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers.
Raebel MA; McClure DL; Simon SR; Chan KA; Feldstein A; Andrade SE; Lafata JE; Roblin D; Davis RL; Gunter MJ; Platt R
Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):55-64. PubMed ID: 16470693
[TBL] [Abstract][Full Text] [Related]
19. Association of consultation between generalists and cardiologists with quality and outcomes of heart failure care.
Ahmed A; Allman RM; Kiefe CI; Person SD; Shaneyfelt TM; Sims RV; Howard G; DeLong JF
Am Heart J; 2003 Jun; 145(6):1086-93. PubMed ID: 12796767
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors.
Morimoto T; Gandhi TK; Fiskio JM; Seger AC; So JW; Cook EF; Fukui T; Bates DW
J Eval Clin Pract; 2004 Nov; 10(4):499-509. PubMed ID: 15482412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
